evidence table

Omega-3 Supplementation Dry Eye Randomized Trial Evidence Table

Name: Omega-3 Supplementation Dry Eye Randomized Trial Evidence Table
Creator: Migaku
License: https://creativecommons.org/licenses/by/4.0/

Structured evidence table for Omega-3 Supplementation Dry Eye Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topic	claim	evidence level	citation	source
Omega-3 Supplementation Dry Eye Randomized Trial	Animal studies have demonstrated that omega-3 fatty acids may decrease glaucoma risk through multiple mechanisms, including lowering IOP, regulating ocular blood flow, providing neuroprotection, and mitigating oxidative stress and inflammation.Clinical studies have also reported an association between omega-3 supplementation and decreases in IOP.	3	Pan Ssu-Yu (2026)	Relationship Between Omega-3 Fatty Acids and Glaucoma Risk in Patients With Dry Eye Disease: A Multinational Retrospective Cohort Study
Omega-3 Supplementation Dry Eye Randomized Trial	Therefore, cohort studies are warranted to investigate the potential long-term benefits of omega-3 supplementation in reducing glaucoma risk.	3	Pan Ssu-Yu (2026)	Relationship Between Omega-3 Fatty Acids and Glaucoma Risk in Patients With Dry Eye Disease: A Multinational Retrospective Cohort Study
Omega-3 Supplementation Dry Eye Randomized Trial	We conducted a retrospective cohort study using a multinational database to examine the comparative risk of glaucoma between individuals with dry eye disease who received omega-3 supplementation and those who did not.	3	Pan Ssu-Yu (2026)	Relationship Between Omega-3 Fatty Acids and Glaucoma Risk in Patients With Dry Eye Disease: A Multinational Retrospective Cohort Study
Omega-3 Supplementation Dry Eye Randomized Trial	A randomized controlled trial conducted by Downie et al.involved 105 participants with dry eye disease and normal baseline IOP, who were randomized to receive either oral omega-3 supplementation or placebo for a duration of 3 months.	3	Pan Ssu-Yu (2026)	Relationship Between Omega-3 Fatty Acids and Glaucoma Risk in Patients With Dry Eye Disease: A Multinational Retrospective Cohort Study
Omega-3 Supplementation Dry Eye Randomized Trial	These innovative therapeutic approaches address the partial limitations of conventional treatments through three main molecular mechanisms: improved drug delivery, multitargeted pharmacology, and enhanced biocompatibility.	4	Liu J (2026)	Advances in Pharmacotherapy and Physiotherapy for Dry Eye Disease: Molecular Mechanisms and Future Directions-A Narrative Literature Review.
Omega-3 Supplementation Dry Eye Randomized Trial	Dry eye disease, a multifactorial and symptomatic disease characterized by tear film instability and ocular surface dysfunction, has emerged as an increasingly pressing global health concern-particularly against the backdrop of increasing digital device usage and the widespread application of virtual learning.	4	Liu J (2026)	Advances in Pharmacotherapy and Physiotherapy for Dry Eye Disease: Molecular Mechanisms and Future Directions-A Narrative Literature Review.
Omega-3 Supplementation Dry Eye Randomized Trial	Traditional pharmacotherapies, such as artificial tears, yield only transient symptomatic relief.	4	Liu J (2026)	Advances in Pharmacotherapy and Physiotherapy for Dry Eye Disease: Molecular Mechanisms and Future Directions-A Narrative Literature Review.